Meropenem Dosing for Bacterial Meningitis
Adult Dosing
For bacterial meningitis in adults, meropenem should be dosed at 2 grams IV every 8 hours when Enterobacteriaceae with suspected ESBL production is isolated or highly suspected. 1
Standard Empiric Therapy
- Meropenem is NOT first-line empiric therapy for community-acquired bacterial meningitis in adults 1
- First-line empiric therapy consists of ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours, plus vancomycin 15-20 mg/kg IV every 12 hours (targeting trough 15-20 μg/mL) 1
- Add amoxicillin 2g IV every 4 hours for patients ≥60 years old to cover Listeria monocytogenes 1
When to Use Meropenem
Meropenem 2g IV every 8 hours is specifically indicated when:
- A member of Enterobacteriaceae is isolated from blood or CSF AND there is high suspicion of ESBL-producing organisms 1
- Treatment duration should be 21 days for Enterobacteriaceae meningitis 1
- Seek specialist infectious disease consultation regarding local antimicrobial resistance patterns 1
Renal Dose Adjustments in Adults
Dosage must be reduced in renal impairment: 2
- CrCl >50 mL/min: 2g every 8 hours (full dose)
- CrCl 26-50 mL/min: 2g every 12 hours
- CrCl 10-25 mL/min: 1g every 12 hours
- CrCl <10 mL/min: 1g every 24 hours
Pediatric Dosing (≥3 Months of Age)
For bacterial meningitis in children ≥3 months old, meropenem is dosed at 40 mg/kg IV every 8 hours (maximum 2 grams per dose). 2
Standard Dosing
- 40 mg/kg IV every 8 hours (maximum 2g per dose) 2
- Administer as IV infusion over 15-30 minutes 2
- For children weighing >50 kg: use adult dose of 2g every 8 hours 2
Important Considerations
- Meropenem is NOT first-line empiric therapy for pediatric bacterial meningitis 1
- First-line empiric therapy for children 1 month to 18 years: cefotaxime 75 mg/kg every 6-8 hours OR ceftriaxone 50 mg/kg every 12 hours (max 2g every 12 hours), PLUS vancomycin 10-15 mg/kg every 6 hours 1
- Meropenem has demonstrated excellent safety and efficacy in pediatric meningitis at the 40 mg/kg dose, with no seizures reported even at this high dose 3, 4
Infants <3 Months of Age
Meropenem dosing for infants <3 months is based on gestational age (GA) and postnatal age (PNA): 2
- GA <32 weeks AND PNA <2 weeks: 20 mg/kg every 12 hours
- GA <32 weeks AND PNA ≥2 weeks: 20 mg/kg every 8 hours
- GA ≥32 weeks AND PNA <2 weeks: 20 mg/kg every 8 hours
- GA ≥32 weeks AND PNA ≥2 weeks: 30 mg/kg every 8 hours
All doses administered as IV infusion over 30 minutes 2
Renal Impairment in Pediatrics
There is no established dosing guidance for pediatric patients with renal impairment. 2
For Children on Continuous Renal Replacement Therapy (CRRT):
- Continuous infusion of 60-120 mg/kg/day is most effective for achieving pharmacodynamic targets 5, 6, 7
- Alternative: 40 mg/kg every 8 hours over 2 hours OR 20 mg/kg every 8 hours over 4 hours 6
- Standard intermittent dosing (40 mg/kg every 12 hours over 30 minutes) achieves target in only 32% of patients on CRRT 6
- Dosing must account for CRRT effluent flow rate and body weight 5, 7
Critical Pitfalls
- Never use meropenem as empiric monotherapy for meningitis—it lacks adequate Gram-positive coverage, particularly for Streptococcus pneumoniae 1
- Meropenem is dialyzable: approximately 50% removed by intermittent hemodialysis 8, 9
- Seizure risk is low even at high meningitis doses (2g every 8 hours in adults, 40 mg/kg every 8 hours in children), with reported incidence of only 0.1% 3, 4, 10
- Half-life dramatically prolonged in renal failure: from 0.9 hours in normal function to 6.8-13.7 hours in end-stage renal disease 8, 9
- Antibiotic therapy must be initiated within 1 hour of hospital presentation in suspected bacterial meningitis—do not delay for imaging or lumbar puncture 1